| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8951 |
| Human Intestinal Absorption | HIA+ | 0.9917 |
| Caco-2 Permeability | Caco2+ | 0.7176 |
| P-glycoprotein Substrate | Non-substrate | 0.6117 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9309 |
| Non-inhibitor | 0.9577 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9190 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9247 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7979 |
| CYP450 2D6 Substrate | Non-substrate | 0.9244 |
| CYP450 3A4 Substrate | Substrate | 0.5803 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7640 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9173 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9298 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9919 |
| Non-inhibitor | 0.9395 |
| AMES Toxicity | Non AMES toxic | 0.9314 |
| Carcinogens | Non-carcinogens | 0.6763 |
| Fish Toxicity | High FHMT | 0.9446 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9279 |
| Honey Bee Toxicity | High HBT | 0.8322 |
| Biodegradation | Not ready biodegradable | 0.9809 |
| Acute Oral Toxicity | III | 0.9172 |
| Carcinogenicity (Three-class) | Danger | 0.3743 |